Enjoy complimentary customisation on priority with our Enterprise License!
According to the market research analysts at Technavio, the infectious disease treatment market in China is anticipated to grow steadily at a CAGR of more than 5% over the forecast period. With the increasing use of combination therapies, the infectious disease treatment market is anticipated to have a positive outlook in the coming years. Physicians are increasingly prescribing drugs that are a combination of anti-infective and corticosteroids. While anti-infectives help reduce the infection, the corticosteroids assist in reducing inflammation of the eye which is caused because of the infection. This helps in proving better efficacy as infections are always associated with inflammation of the conjunctival and corneal tissue, resulting in increased irritation. For instance, some common drugs used are Neo-Poly-Dex eye drops by Bausch & Lomb and Maxitrol by Alcon, which contain polymyxin B sulfates and neomycin and dexamethasone.
One of the significant trends spurring the growth of this market is the emergence of interferon-free therapies in the treatment of infectious diseases. At present, hepatitis C treatment relies on the administration of interferon-based therapies in combination with ribavirin. This treatment is associated with several adverse effects such as anemia and leukopenia. Therefore, researchers and vendors are focusing on developing DAAs with minimal side-effects compared to current treatment methods. Moreover, these therapies are intended to be all-oral regimens and once approved; they are anticipated to have a positive effect on the market. The launch of IFN-free therapies is expected to increase significantly the market sales of hepatitis drugs, which will bolster the growth of the infectious disease treatment market in China over the next four years.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: China - An overview
PART 06: Opportunities for global and local vendors
PART 07: Pipeline analysis
PART 09: Market segmentation by application
PART 10: Antibacterial drugs market in China
PART 11: Antiviral drugs market in China
PART 12: Antifungal drugs market in China
PART 13: Antiparasitic drugs market in China
PART 14: Market drivers
PART 15: Impact of drivers
PART 16: Market challenges
PART 17: Impact of drivers and challenges
PART 18: Market trends
PART 19: Vendor landscape
PART 20: Appendix
PART 21: Explore Technavio
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.